

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NADH metabolic process (GO:0006734) | 5.93970796 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.84514308 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.84514308 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.74902611 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.74902611 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58790479 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.57272109 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 5.27556047 |
| 9 | regulation of triglyceride catabolic process (GO:0010896) | 5.25260365 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.16146232 |
| 11 | diacylglycerol metabolic process (GO:0046339) | 5.01006839 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95358606 |
| 13 | urea cycle (GO:0000050) | 4.77709398 |
| 14 | urea metabolic process (GO:0019627) | 4.77709398 |
| 15 | complement activation, alternative pathway (GO:0006957) | 4.76868315 |
| 16 | cysteine metabolic process (GO:0006534) | 4.72073625 |
| 17 | glyoxylate metabolic process (GO:0046487) | 4.65380272 |
| 18 | biotin metabolic process (GO:0006768) | 4.64589587 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 4.63909568 |
| 20 | plasma lipoprotein particle clearance (GO:0034381) | 4.61598358 |
| 21 | amino-acid betaine metabolic process (GO:0006577) | 4.60654017 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.59539828 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 4.59461853 |
| 24 | indole-containing compound catabolic process (GO:0042436) | 4.57186688 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 4.57186688 |
| 26 | tryptophan catabolic process (GO:0006569) | 4.57186688 |
| 27 | regulation of sequestering of triglyceride (GO:0010889) | 4.55970296 |
| 28 | valine metabolic process (GO:0006573) | 4.54863549 |
| 29 | acylglycerol homeostasis (GO:0055090) | 4.53499071 |
| 30 | triglyceride homeostasis (GO:0070328) | 4.53499071 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.52469559 |
| 32 | kynurenine metabolic process (GO:0070189) | 4.52393812 |
| 33 | angiotensin maturation (GO:0002003) | 4.46411384 |
| 34 | acetyl-CoA metabolic process (GO:0006084) | 4.45996457 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.44798030 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.35043892 |
| 37 | regulation of protein activation cascade (GO:2000257) | 4.33271889 |
| 38 | fatty acid oxidation (GO:0019395) | 4.32545537 |
| 39 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.32443032 |
| 40 | lysine metabolic process (GO:0006553) | 4.31609671 |
| 41 | lysine catabolic process (GO:0006554) | 4.31609671 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.31133757 |
| 43 | tryptophan metabolic process (GO:0006568) | 4.30384625 |
| 44 | fatty acid catabolic process (GO:0009062) | 4.25163539 |
| 45 | negative regulation of fibrinolysis (GO:0051918) | 4.24716795 |
| 46 | lipid oxidation (GO:0034440) | 4.23451734 |
| 47 | positive regulation of lipid catabolic process (GO:0050996) | 4.20709276 |
| 48 | triglyceride catabolic process (GO:0019433) | 4.18649992 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.18561368 |
| 50 | protein carboxylation (GO:0018214) | 4.14482011 |
| 51 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.14482011 |
| 52 | regulation of complement activation (GO:0030449) | 4.11406496 |
| 53 | bile acid metabolic process (GO:0008206) | 4.10692409 |
| 54 | acylglycerol catabolic process (GO:0046464) | 4.02880079 |
| 55 | neutral lipid catabolic process (GO:0046461) | 4.02880079 |
| 56 | regulation of fibrinolysis (GO:0051917) | 4.00084689 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.96535086 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.96535086 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.96535086 |
| 60 | regulation of cholesterol esterification (GO:0010872) | 3.95793076 |
| 61 | carnitine shuttle (GO:0006853) | 3.95202527 |
| 62 | glycine metabolic process (GO:0006544) | 3.92143279 |
| 63 | monocarboxylic acid catabolic process (GO:0072329) | 3.90878459 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 3.90348799 |
| 65 | reverse cholesterol transport (GO:0043691) | 3.90040237 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.89101078 |
| 67 | fatty acid homeostasis (GO:0055089) | 3.87747306 |
| 68 | aromatic amino acid family metabolic process (GO:0009072) | 3.86811016 |
| 69 | carnitine metabolic process (GO:0009437) | 3.85526195 |
| 70 | positive regulation of fatty acid oxidation (GO:0046321) | 3.85266533 |
| 71 | ethanol oxidation (GO:0006069) | 3.83609612 |
| 72 | phospholipid efflux (GO:0033700) | 3.81240859 |
| 73 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.79674444 |
| 74 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76192133 |
| 75 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76192133 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75603897 |
| 77 | tyrosine metabolic process (GO:0006570) | 3.74794266 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 3.74441262 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 3.73287932 |
| 80 | lipid storage (GO:0019915) | 3.70312237 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.68498298 |
| 82 | organic acid catabolic process (GO:0016054) | 3.68498298 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.68268867 |
| 84 | regulation of cholesterol storage (GO:0010885) | 3.68092203 |
| 85 | branched-chain amino acid metabolic process (GO:0009081) | 3.67635845 |
| 86 | phospholipid homeostasis (GO:0055091) | 3.67261173 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 3.66743783 |
| 88 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.62621860 |
| 89 | regulation of triglyceride metabolic process (GO:0090207) | 3.61391809 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 3.58600577 |
| 91 | thioester biosynthetic process (GO:0035384) | 3.55686709 |
| 92 | acyl-CoA biosynthetic process (GO:0071616) | 3.55686709 |
| 93 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.54760453 |
| 94 | glycerolipid catabolic process (GO:0046503) | 3.54493628 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.52974363 |
| 96 | negative regulation of cholesterol transport (GO:0032375) | 3.52092516 |
| 97 | negative regulation of sterol transport (GO:0032372) | 3.52092516 |
| 98 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.50400433 |
| 99 | coenzyme catabolic process (GO:0009109) | 3.49452571 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 3.48975389 |
| 101 | bile acid and bile salt transport (GO:0015721) | 3.48649458 |
| 102 | transcytosis (GO:0045056) | 3.48616482 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.48528061 |
| 104 | serine family amino acid biosynthetic process (GO:0009070) | 3.47708491 |
| 105 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.45590157 |
| 106 | sterol homeostasis (GO:0055092) | 3.42492218 |
| 107 | regulation of fatty acid oxidation (GO:0046320) | 3.41725923 |
| 108 | * triglyceride metabolic process (GO:0006641) | 3.39346108 |
| 109 | regulation of cholesterol metabolic process (GO:0090181) | 3.38844688 |
| 110 | ethanol metabolic process (GO:0006067) | 3.38672331 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 3.37218321 |
| 112 | barbed-end actin filament capping (GO:0051016) | 3.30112175 |
| 113 | * triglyceride biosynthetic process (GO:0019432) | 3.25121181 |
| 114 | tricarboxylic acid metabolic process (GO:0072350) | 3.19054447 |
| 115 | fructose metabolic process (GO:0006000) | 3.15416504 |
| 116 | * neutral lipid biosynthetic process (GO:0046460) | 3.08517452 |
| 117 | * acylglycerol biosynthetic process (GO:0046463) | 3.08517452 |
| 118 | * acylglycerol metabolic process (GO:0006639) | 3.07168923 |
| 119 | positive regulation of cholesterol efflux (GO:0010875) | 3.05560321 |
| 120 | * neutral lipid metabolic process (GO:0006638) | 3.01117285 |
| 121 | intestinal absorption (GO:0050892) | 2.99935388 |
| 122 | primary alcohol metabolic process (GO:0034308) | 2.95960821 |
| 123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.95162799 |
| 124 | lipoprotein transport (GO:0042953) | 2.94126014 |
| 125 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.88725418 |
| 126 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.79795467 |
| 127 | regulation of cholesterol transport (GO:0032374) | 2.78179035 |
| 128 | regulation of sterol transport (GO:0032371) | 2.78179035 |
| 129 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.77992453 |
| 130 | adhesion of symbiont to host cell (GO:0044650) | 2.76735982 |
| 131 | virion attachment to host cell (GO:0019062) | 2.76735982 |
| 132 | epoxygenase P450 pathway (GO:0019373) | 2.75697206 |
| 133 | primary alcohol catabolic process (GO:0034310) | 2.73076233 |
| 134 | cellular response to cadmium ion (GO:0071276) | 2.72050893 |
| 135 | brown fat cell differentiation (GO:0050873) | 2.71978297 |
| 136 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.69842585 |
| 137 | adhesion of symbiont to host (GO:0044406) | 2.68991712 |
| 138 | daunorubicin metabolic process (GO:0044597) | 2.66944141 |
| 139 | polyketide metabolic process (GO:0030638) | 2.66944141 |
| 140 | doxorubicin metabolic process (GO:0044598) | 2.66944141 |
| 141 | positive regulation of cholesterol transport (GO:0032376) | 2.64436451 |
| 142 | positive regulation of sterol transport (GO:0032373) | 2.64436451 |
| 143 | very long-chain fatty acid metabolic process (GO:0000038) | 2.63677244 |
| 144 | glycerol metabolic process (GO:0006071) | 2.61950926 |
| 145 | alditol metabolic process (GO:0019400) | 2.61948855 |
| 146 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.61409961 |
| 147 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.61154317 |
| 148 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.60540938 |
| 149 | response to phenylpropanoid (GO:0080184) | 2.52756947 |
| 150 | regulation of lipid catabolic process (GO:0050994) | 2.52575391 |
| 151 | positive regulation of lipid storage (GO:0010884) | 2.51912939 |
| 152 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.49112551 |
| 153 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.48468742 |
| 154 | white fat cell differentiation (GO:0050872) | 2.47480897 |
| 155 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.47122360 |
| 156 | retinol metabolic process (GO:0042572) | 2.45727197 |
| 157 | proline biosynthetic process (GO:0006561) | 2.45500821 |
| 158 | glycosphingolipid catabolic process (GO:0046479) | 2.44613210 |
| 159 | glomerular filtration (GO:0003094) | 2.41275325 |
| 160 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.41187664 |
| 161 | GDP-mannose metabolic process (GO:0019673) | 2.41090296 |
| 162 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.39868280 |
| 163 | response to hydroperoxide (GO:0033194) | 2.38776112 |
| 164 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.37691033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.38204731 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.71036335 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.73602286 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.00868107 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.17854881 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.04111310 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.24647112 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12449151 |
| 9 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.82621301 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.23800484 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.13825265 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58358763 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44191108 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.40860483 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07616718 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70192709 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70105753 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68477433 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68132995 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66474237 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65866444 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.62526154 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54475816 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54257731 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52601015 |
| 26 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50876728 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49832714 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47884328 |
| 29 | * P68_20966046_ChIP-Seq_HELA_Human | 1.44071514 |
| 30 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42309429 |
| 31 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36966621 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32635916 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32508359 |
| 34 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30983978 |
| 35 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30938849 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28959127 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28512990 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27401127 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25056824 |
| 40 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24969837 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24744279 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23320816 |
| 43 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23165237 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18808800 |
| 45 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17656673 |
| 46 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.16255875 |
| 47 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14475557 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13244864 |
| 49 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12683546 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10941737 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10611950 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10347738 |
| 53 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09524536 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09395402 |
| 55 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08746331 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08413354 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07966924 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07873889 |
| 59 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07423060 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05675421 |
| 61 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05332047 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03950974 |
| 63 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03103311 |
| 64 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02920618 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.02810544 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02466040 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02220472 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01830965 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01712303 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00852537 |
| 71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00508892 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98708370 |
| 73 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97705997 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97654365 |
| 75 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97416690 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97367253 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97310503 |
| 78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97001141 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96778159 |
| 80 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96600863 |
| 81 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.96198484 |
| 82 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96194701 |
| 83 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95820778 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95360892 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95032920 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94501421 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94383894 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94100774 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94048117 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93717746 |
| 91 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92995923 |
| 92 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86712664 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85776958 |
| 94 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79087846 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77894492 |
| 96 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75786918 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.75487189 |
| 98 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75140494 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.73856175 |
| 100 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73348608 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73302981 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72471323 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71969106 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71774858 |
| 105 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.71582094 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70600450 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70266005 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69222254 |
| 109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68898467 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.68043777 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 0.67947269 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.67295387 |
| 113 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67013677 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66838588 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66687581 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66023839 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65269520 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.63584579 |
| 119 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.63210396 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62908715 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60247820 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.59005581 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.58790237 |
| 124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.58264222 |
| 125 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.58126156 |
| 126 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.57892185 |
| 127 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.57335818 |
| 128 | * P300_27268052_Chip-Seq_Bcells_Human | 0.57195908 |
| 129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57035093 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.56647401 |
| 131 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.56439215 |
| 132 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.56013081 |
| 133 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.55639256 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.55422447 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54836218 |
| 136 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.54425537 |
| 137 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.54343934 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.54323733 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52493515 |
| 140 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.52473727 |
| 141 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.52322082 |
| 142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.51847120 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.51796856 |
| 144 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.51282462 |
| 145 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.51195172 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51145351 |
| 147 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.50410325 |
| 148 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.50314517 |
| 149 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.49982147 |
| 150 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.49561536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.64859456 |
| 2 | MP0005360_urolithiasis | 6.16435197 |
| 3 | MP0005365_abnormal_bile_salt | 5.29504633 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.93532994 |
| 5 | MP0010329_abnormal_lipoprotein_level | 3.86345098 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.75812774 |
| 7 | MP0005670_abnormal_white_adipose | 3.73654733 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.58403191 |
| 9 | MP0009840_abnormal_foam_cell | 3.49160953 |
| 10 | MP0003252_abnormal_bile_duct | 2.91366816 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.88730352 |
| 12 | MP0005332_abnormal_amino_acid | 2.58864322 |
| 13 | MP0005666_abnormal_adipose_tissue | 2.42963203 |
| 14 | * MP0002118_abnormal_lipid_homeostasis | 2.40385483 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.35517201 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.30815662 |
| 17 | MP0004130_abnormal_muscle_cell | 2.25816634 |
| 18 | MP0005083_abnormal_biliary_tract | 2.04743710 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.99076006 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.91112401 |
| 21 | MP0003195_calcinosis | 1.90533517 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 1.89042148 |
| 23 | MP0003186_abnormal_redox_activity | 1.86176545 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.84640339 |
| 25 | MP0001764_abnormal_homeostasis | 1.80488104 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.71330259 |
| 27 | * MP0002971_abnormal_brown_adipose | 1.65029171 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62010129 |
| 29 | MP0004858_abnormal_nervous_system | 1.52687535 |
| 30 | MP0005375_adipose_tissue_phenotype | 1.48031486 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.43244579 |
| 32 | MP0000858_altered_metastatic_potential | 1.42669726 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.41944913 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.40458394 |
| 35 | MP0003303_peritoneal_inflammation | 1.39964789 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.39960804 |
| 37 | * MP0005334_abnormal_fat_pad | 1.35296083 |
| 38 | MP0009115_abnormal_fat_cell | 1.35068409 |
| 39 | MP0003828_pulmonary_edema | 1.31667564 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.28871682 |
| 41 | MP0001661_extended_life_span | 1.27446390 |
| 42 | MP0003075_altered_response_to | 1.23921922 |
| 43 | MP0005451_abnormal_body_composition | 1.21400633 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.20528126 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.20515398 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.19237464 |
| 47 | MP0003011_delayed_dark_adaptation | 1.19210672 |
| 48 | * MP0000598_abnormal_liver_morphology | 1.19173154 |
| 49 | MP0008260_abnormal_autophagy | 1.17364042 |
| 50 | MP0003868_abnormal_feces_composition | 1.15932515 |
| 51 | MP0009697_abnormal_copulation | 1.14687771 |
| 52 | MP0003724_increased_susceptibility_to | 1.11249770 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.10251734 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.08905631 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.08905631 |
| 56 | MP0005409_darkened_coat_color | 1.08540850 |
| 57 | * MP0002970_abnormal_white_adipose | 1.07486914 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.07224055 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.06978168 |
| 60 | MP0005166_decreased_susceptibility_to | 1.05264040 |
| 61 | MP0009278_abnormal_bone_marrow | 1.05127331 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.04324532 |
| 63 | MP0002254_reproductive_system_inflammat | 1.03143981 |
| 64 | MP0009763_increased_sensitivity_to | 1.02220483 |
| 65 | MP0005448_abnormal_energy_balance | 1.01924703 |
| 66 | * MP0002078_abnormal_glucose_homeostasis | 1.01627316 |
| 67 | * MP0005535_abnormal_body_temperature | 1.01146395 |
| 68 | MP0005501_abnormal_skin_physiology | 1.00149649 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.98461294 |
| 70 | MP0005165_increased_susceptibility_to | 0.96781968 |
| 71 | MP0005025_abnormal_response_to | 0.95628843 |
| 72 | MP0004272_abnormal_basement_membrane | 0.95014164 |
| 73 | MP0002419_abnormal_innate_immunity | 0.94816089 |
| 74 | MP0008469_abnormal_protein_level | 0.94127535 |
| 75 | MP0001756_abnormal_urination | 0.93469123 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.87821288 |
| 77 | MP0005647_abnormal_sex_gland | 0.87595903 |
| 78 | * MP0009642_abnormal_blood_homeostasis | 0.86297168 |
| 79 | MP0000678_abnormal_parathyroid_gland | 0.86224360 |
| 80 | MP0003279_aneurysm | 0.85932125 |
| 81 | MP0005376_homeostasis/metabolism_phenot | 0.85378512 |
| 82 | MP0009764_decreased_sensitivity_to | 0.84928854 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.84671872 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.82080234 |
| 85 | MP0003329_amyloid_beta_deposits | 0.81560308 |
| 86 | MP0004947_skin_inflammation | 0.80701088 |
| 87 | MP0003866_abnormal_defecation | 0.79774615 |
| 88 | MP0000490_abnormal_crypts_of | 0.79505379 |
| 89 | MP0000604_amyloidosis | 0.78926855 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.78092115 |
| 91 | MP0002796_impaired_skin_barrier | 0.77906596 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 0.77661573 |
| 93 | MP0005266_abnormal_metabolism | 0.76870217 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.75857074 |
| 95 | MP0000751_myopathy | 0.75787571 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.75314215 |
| 97 | MP0003448_altered_tumor_morphology | 0.74894147 |
| 98 | MP0001849_ear_inflammation | 0.74867889 |
| 99 | MP0005275_abnormal_skin_tensile | 0.72977788 |
| 100 | MP0001853_heart_inflammation | 0.72349210 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.70995359 |
| 102 | MP0001881_abnormal_mammary_gland | 0.70901815 |
| 103 | MP0006035_abnormal_mitochondrial_morpho | 0.68568981 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.68078761 |
| 105 | MP0010368_abnormal_lymphatic_system | 0.67125314 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.66740524 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.66708752 |
| 108 | MP0003436_decreased_susceptibility_to | 0.63025583 |
| 109 | MP0003959_abnormal_lean_body | 0.62914816 |
| 110 | MP0002060_abnormal_skin_morphology | 0.62755805 |
| 111 | MP0003690_abnormal_glial_cell | 0.62571451 |
| 112 | MP0003646_muscle_fatigue | 0.62475201 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.62349967 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.61932343 |
| 115 | MP0000013_abnormal_adipose_tissue | 0.60321846 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.60190732 |
| 117 | * MP0003953_abnormal_hormone_level | 0.55392933 |
| 118 | * MP0005452_abnormal_adipose_tissue | 0.55286516 |
| 119 | MP0005395_other_phenotype | 0.54910171 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.54635255 |
| 121 | MP0003718_maternal_effect | 0.52008368 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50325288 |
| 123 | MP0005330_cardiomyopathy | 0.50044389 |
| 124 | MP0000249_abnormal_blood_vessel | 0.49517387 |
| 125 | MP0006138_congestive_heart_failure | 0.47162481 |
| 126 | MP0009672_abnormal_birth_weight | 0.47113944 |
| 127 | MP0005164_abnormal_response_to | 0.44963205 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.43149969 |
| 129 | MP0000343_altered_response_to | 0.42961629 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.41664426 |
| 131 | MP0005023_abnormal_wound_healing | 0.41231358 |
| 132 | MP0002168_other_aberrant_phenotype | 0.41069601 |
| 133 | MP0004147_increased_porphyrin_level | 0.40940436 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.39985817 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.39502715 |
| 136 | MP0001544_abnormal_cardiovascular_syste | 0.39502715 |
| 137 | MP0008873_increased_physiological_sensi | 0.38965710 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.38536913 |
| 139 | MP0009785_altered_susceptibility_to | 0.38272169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Xanthomatosis (HP:0000991) | 5.79352200 |
| 2 | Hyperglycinuria (HP:0003108) | 5.69873506 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.64200898 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.51724993 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.50103084 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.25814267 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.16249444 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 5.11814160 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.11814160 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.02948901 |
| 11 | Hyperammonemia (HP:0001987) | 4.95037752 |
| 12 | Complement deficiency (HP:0004431) | 4.89317495 |
| 13 | Hyperglycinemia (HP:0002154) | 4.85080811 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.71583551 |
| 15 | Hypoglycemic coma (HP:0001325) | 4.66832007 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.50655444 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.46694163 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.43666020 |
| 19 | Ketosis (HP:0001946) | 4.37536699 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26623144 |
| 21 | Epidermoid cyst (HP:0200040) | 4.14388051 |
| 22 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.13519056 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09614481 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.76430822 |
| 25 | Dicarboxylic aciduria (HP:0003215) | 3.76430822 |
| 26 | Abnormality of complement system (HP:0005339) | 3.61617684 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.46268925 |
| 28 | Joint hemorrhage (HP:0005261) | 3.45686872 |
| 29 | Ketoacidosis (HP:0001993) | 3.42094259 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39804119 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.36066843 |
| 32 | Abnormality of serum amino acid levels (HP:0003112) | 3.33614318 |
| 33 | Vertebral compression fractures (HP:0002953) | 3.33271218 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.32882947 |
| 35 | Fat malabsorption (HP:0002630) | 3.15132766 |
| 36 | Axonal loss (HP:0003447) | 3.12869480 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.12016610 |
| 38 | Myocardial infarction (HP:0001658) | 3.05693232 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.04389055 |
| 40 | Lethargy (HP:0001254) | 3.04052410 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.01235013 |
| 42 | * Hypertriglyceridemia (HP:0002155) | 2.93980333 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 2.89600907 |
| 44 | Hydroxyprolinuria (HP:0003080) | 2.89600907 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.85752032 |
| 46 | Metabolic acidosis (HP:0001942) | 2.82304355 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81322439 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.79784290 |
| 49 | Nausea (HP:0002018) | 2.79587062 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.74390482 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74390482 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.74390482 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.73107609 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.71366153 |
| 55 | Skin nodule (HP:0200036) | 2.70265803 |
| 56 | Myoglobinuria (HP:0002913) | 2.66500920 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.63558977 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.62313185 |
| 59 | Delayed CNS myelination (HP:0002188) | 2.60516538 |
| 60 | Cerebral edema (HP:0002181) | 2.59244718 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.57666900 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.52613415 |
| 63 | Oligomenorrhea (HP:0000876) | 2.52587835 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.51840152 |
| 65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.46453627 |
| 66 | Vomiting (HP:0002013) | 2.39238117 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.38900833 |
| 68 | * Pancreatitis (HP:0001733) | 2.35211220 |
| 69 | Brushfield spots (HP:0001088) | 2.34536713 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.30432074 |
| 71 | Steatorrhea (HP:0002570) | 2.29486062 |
| 72 | Hepatocellular carcinoma (HP:0001402) | 2.28908230 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28810470 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28810470 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28810470 |
| 76 | Hemorrhage of the eye (HP:0011885) | 2.27708479 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26481050 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.26481050 |
| 79 | Hyperparathyroidism (HP:0000843) | 2.26388837 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.25864429 |
| 81 | Spastic diplegia (HP:0001264) | 2.24300932 |
| 82 | Proximal tubulopathy (HP:0000114) | 2.22380380 |
| 83 | Renal cortical cysts (HP:0000803) | 2.22310147 |
| 84 | Colitis (HP:0002583) | 2.22015129 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.20478467 |
| 86 | Hepatic necrosis (HP:0002605) | 2.19566702 |
| 87 | Cervical subluxation (HP:0003308) | 2.19158005 |
| 88 | Distal lower limb muscle weakness (HP:0009053) | 2.18938582 |
| 89 | Premature rupture of membranes (HP:0001788) | 2.18240648 |
| 90 | Increased connective tissue (HP:0009025) | 2.18132578 |
| 91 | Subcapsular cataract (HP:0000523) | 2.17994220 |
| 92 | Hyperglycemia (HP:0003074) | 2.16219518 |
| 93 | Polygenic inheritance (HP:0010982) | 2.15953999 |
| 94 | Irritability (HP:0000737) | 2.15235175 |
| 95 | Spontaneous abortion (HP:0005268) | 2.15176079 |
| 96 | Gout (HP:0001997) | 2.14862503 |
| 97 | Thin bony cortex (HP:0002753) | 2.14075070 |
| 98 | Esophageal varix (HP:0002040) | 2.12322110 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.07174675 |
| 100 | Multiple enchondromatosis (HP:0005701) | 2.07065345 |
| 101 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06249334 |
| 102 | Malnutrition (HP:0004395) | 2.05563408 |
| 103 | Purpura (HP:0000979) | 2.05561223 |
| 104 | Nephritis (HP:0000123) | 2.04431406 |
| 105 | Gastrointestinal dysmotility (HP:0002579) | 2.01012766 |
| 106 | Stridor (HP:0010307) | 2.00961815 |
| 107 | Acanthocytosis (HP:0001927) | 2.00617665 |
| 108 | Elevated hepatic transaminases (HP:0002910) | 2.00161883 |
| 109 | * Insulin resistance (HP:0000855) | 1.99951058 |
| 110 | Late onset (HP:0003584) | 1.99428445 |
| 111 | Amyloidosis (HP:0011034) | 1.98289276 |
| 112 | Gingivitis (HP:0000230) | 1.95292514 |
| 113 | * Acanthosis nigricans (HP:0000956) | 1.95059508 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.94540531 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.93931520 |
| 116 | Cholelithiasis (HP:0001081) | 1.93729852 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 1.93228721 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.92819424 |
| 119 | Multiple lipomas (HP:0001012) | 1.92664859 |
| 120 | Abnormality of the nasal mucosa (HP:0000433) | 1.92155093 |
| 121 | Wide cranial sutures (HP:0010537) | 1.91499794 |
| 122 | Abnormality of macrophages (HP:0004311) | 1.91182508 |
| 123 | Cerebral palsy (HP:0100021) | 1.90764309 |
| 124 | Neonatal onset (HP:0003623) | 1.90763312 |
| 125 | Widely patent fontanelles and sutures (HP:0004492) | 1.90546837 |
| 126 | Hypercortisolism (HP:0001578) | 1.90390067 |
| 127 | Glomerulonephritis (HP:0000099) | 1.89854836 |
| 128 | Petechiae (HP:0000967) | 1.89809430 |
| 129 | Bulbar palsy (HP:0001283) | 1.89191671 |
| 130 | Hypophosphatemia (HP:0002148) | 1.89125058 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 1.88267222 |
| 132 | Polycythemia (HP:0001901) | 1.88097826 |
| 133 | Ragged-red muscle fibers (HP:0003200) | 1.87661933 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.87586413 |
| 135 | Hyperuricemia (HP:0002149) | 1.87322024 |
| 136 | Increased purine levels (HP:0004368) | 1.87322024 |
| 137 | Ileus (HP:0002595) | 1.86067637 |
| 138 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85317431 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85186079 |
| 140 | Glycosuria (HP:0003076) | 1.84260380 |
| 141 | Abnormality of urine glucose concentration (HP:0011016) | 1.84260380 |
| 142 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82528291 |
| 143 | Loss of speech (HP:0002371) | 1.82397606 |
| 144 | Increased serum ferritin (HP:0003281) | 1.81447606 |
| 145 | Vascular calcification (HP:0004934) | 1.80660453 |
| 146 | Pigmentary retinal degeneration (HP:0001146) | 1.80170145 |
| 147 | Back pain (HP:0003418) | 1.79921718 |
| 148 | Achilles tendon contracture (HP:0001771) | 1.79338863 |
| 149 | Methylmalonic aciduria (HP:0012120) | 1.79249052 |
| 150 | Opisthotonus (HP:0002179) | 1.78784925 |
| 151 | Abdominal distention (HP:0003270) | 1.78012416 |
| 152 | Abnormality of the Achilles tendon (HP:0005109) | 1.78010800 |
| 153 | Bone pain (HP:0002653) | 1.77371388 |
| 154 | Easy fatigability (HP:0003388) | 1.75741939 |
| 155 | Cerebral aneurysm (HP:0004944) | 1.75505006 |
| 156 | Prolonged neonatal jaundice (HP:0006579) | 1.73649755 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.73229197 |
| 158 | Abnormality of carpal bone ossification (HP:0006257) | 1.72929321 |
| 159 | Spinal rigidity (HP:0003306) | 1.69539306 |
| 160 | Pathologic fracture (HP:0002756) | 1.69301139 |
| 161 | Osteolytic defects of the hand bones (HP:0009699) | 1.69251956 |
| 162 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69251956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.84104620 |
| 2 | TRIB3 | 4.07283382 |
| 3 | SIK1 | 4.00394669 |
| 4 | ERN1 | 3.86454152 |
| 5 | CAMK1D | 3.72904859 |
| 6 | FGFR4 | 2.82881978 |
| 7 | TESK1 | 2.82007026 |
| 8 | PDK3 | 2.70526617 |
| 9 | PDK4 | 2.70526617 |
| 10 | EPHB2 | 2.22894800 |
| 11 | MST1R | 2.22059424 |
| 12 | PKN2 | 2.09916187 |
| 13 | CAMK1G | 2.06850197 |
| 14 | PRPF4B | 2.06505994 |
| 15 | FLT3 | 1.97192657 |
| 16 | SMG1 | 1.94994757 |
| 17 | PDK2 | 1.73406591 |
| 18 | INSRR | 1.73261646 |
| 19 | EPHA2 | 1.69980861 |
| 20 | DDR2 | 1.62206524 |
| 21 | IRAK3 | 1.58936493 |
| 22 | PRKAA2 | 1.54436550 |
| 23 | RIPK4 | 1.48324592 |
| 24 | ARAF | 1.47209395 |
| 25 | KDR | 1.44808433 |
| 26 | MAPK11 | 1.43933579 |
| 27 | NEK9 | 1.43779643 |
| 28 | MAP2K3 | 1.37300883 |
| 29 | FRK | 1.35261495 |
| 30 | PIM2 | 1.30611754 |
| 31 | RIPK1 | 1.30575104 |
| 32 | PAK4 | 1.25581475 |
| 33 | MAP3K3 | 1.23826186 |
| 34 | TIE1 | 1.20694827 |
| 35 | TYK2 | 1.19338799 |
| 36 | MAP3K1 | 1.16265126 |
| 37 | TAOK3 | 1.15705374 |
| 38 | ABL2 | 1.13826235 |
| 39 | PINK1 | 1.11663214 |
| 40 | LATS1 | 1.09288793 |
| 41 | CDK6 | 1.06604579 |
| 42 | NME2 | 1.02660858 |
| 43 | MAP3K11 | 1.00336322 |
| 44 | ERBB4 | 0.99102210 |
| 45 | EEF2K | 0.97806172 |
| 46 | PIK3CG | 0.96621123 |
| 47 | CDK4 | 0.94223699 |
| 48 | TAOK1 | 0.92693921 |
| 49 | PTK2 | 0.87564917 |
| 50 | PRKAA1 | 0.86037310 |
| 51 | PTK6 | 0.84641470 |
| 52 | JAK2 | 0.82724508 |
| 53 | TGFBR2 | 0.82663028 |
| 54 | EIF2AK1 | 0.82470863 |
| 55 | TBK1 | 0.82111979 |
| 56 | ILK | 0.80969673 |
| 57 | WEE1 | 0.80657680 |
| 58 | PRKD2 | 0.78064808 |
| 59 | CDC42BPA | 0.77778044 |
| 60 | MET | 0.75916321 |
| 61 | BMX | 0.74421291 |
| 62 | JAK1 | 0.74371262 |
| 63 | BLK | 0.73864061 |
| 64 | SCYL2 | 0.73431917 |
| 65 | GRK6 | 0.72680581 |
| 66 | MAP3K13 | 0.70705411 |
| 67 | PDPK1 | 0.70651581 |
| 68 | MAP2K1 | 0.68547815 |
| 69 | NEK1 | 0.68545189 |
| 70 | MAPK4 | 0.65374581 |
| 71 | LMTK2 | 0.64135584 |
| 72 | IRAK4 | 0.61714841 |
| 73 | RPS6KA2 | 0.61592258 |
| 74 | PRKG2 | 0.59415136 |
| 75 | CSF1R | 0.59331621 |
| 76 | MTOR | 0.58554745 |
| 77 | PRKACG | 0.58518067 |
| 78 | MYLK | 0.57758461 |
| 79 | FGFR3 | 0.57533882 |
| 80 | MAP2K2 | 0.56934680 |
| 81 | STK38L | 0.56829418 |
| 82 | MAP4K1 | 0.56283520 |
| 83 | KSR2 | 0.55972519 |
| 84 | FGFR2 | 0.54597986 |
| 85 | ZAP70 | 0.54303473 |
| 86 | DAPK3 | 0.53308202 |
| 87 | EPHB1 | 0.53217829 |
| 88 | GSK3A | 0.52927246 |
| 89 | CSK | 0.51969528 |
| 90 | BUB1 | 0.51554910 |
| 91 | RPS6KC1 | 0.51352762 |
| 92 | RPS6KL1 | 0.51352762 |
| 93 | LATS2 | 0.50564505 |
| 94 | MAP3K10 | 0.50523407 |
| 95 | MATK | 0.48490370 |
| 96 | PDK1 | 0.48056848 |
| 97 | BRSK2 | 0.46360434 |
| 98 | ACVR1B | 0.45583265 |
| 99 | MAP3K2 | 0.45513562 |
| 100 | BRAF | 0.45174614 |
| 101 | MAP3K6 | 0.42874870 |
| 102 | LRRK2 | 0.42073846 |
| 103 | MOS | 0.41454737 |
| 104 | STK3 | 0.41331988 |
| 105 | JAK3 | 0.41257053 |
| 106 | FES | 0.40939889 |
| 107 | MAP3K14 | 0.40935639 |
| 108 | MAP2K4 | 0.40037742 |
| 109 | MAP3K8 | 0.39290055 |
| 110 | CDK9 | 0.38967536 |
| 111 | PDGFRA | 0.38696646 |
| 112 | TAOK2 | 0.38355821 |
| 113 | IKBKB | 0.37351740 |
| 114 | MAPK12 | 0.37299470 |
| 115 | MAPKAPK2 | 0.36690264 |
| 116 | MAP3K7 | 0.35784369 |
| 117 | HIPK2 | 0.35493463 |
| 118 | PRKD1 | 0.34835316 |
| 119 | IRAK2 | 0.34741688 |
| 120 | GRK5 | 0.34522779 |
| 121 | AKT3 | 0.33875194 |
| 122 | MAP2K6 | 0.33740724 |
| 123 | TNK2 | 0.33718332 |
| 124 | IGF1R | 0.33341666 |
| 125 | EIF2AK3 | 0.33046761 |
| 126 | STK16 | 0.32643325 |
| 127 | KIT | 0.31852157 |
| 128 | MAP3K5 | 0.31367609 |
| 129 | ICK | 0.31249524 |
| 130 | PRKCZ | 0.30449137 |
| 131 | EIF2AK2 | 0.29419891 |
| 132 | TTK | 0.28351723 |
| 133 | EPHA3 | 0.28231890 |
| 134 | MAPKAPK3 | 0.27520515 |
| 135 | NLK | 0.25875765 |
| 136 | TTN | 0.25666762 |
| 137 | IRAK1 | 0.25236963 |
| 138 | DYRK1B | 0.25099139 |
| 139 | TESK2 | 0.24553496 |
| 140 | NEK2 | 0.24501713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.57265430 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.05949394 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.00352917 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.95477681 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88667612 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.83900610 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.69997713 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.67028206 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.59773821 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46346229 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40436340 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38562590 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34682036 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33272212 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.30201107 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.26964035 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.13879440 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13804943 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02854172 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01665606 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.97323400 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.91655198 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.86167622 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84212440 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.80104792 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.73363819 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73320757 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72788026 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62357211 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61826082 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56025752 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55181773 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55107406 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52477855 |
| 35 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49760470 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.46613615 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44620044 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40172253 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38303288 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37228143 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36996067 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.34717523 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34615594 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30598084 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25179438 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24117965 |
| 47 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21868437 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19651943 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17101980 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.16821804 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.14375045 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14093194 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10240170 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.06986586 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.02105895 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96033004 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92134041 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90568156 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85783844 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84762871 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80283392 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79049907 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76856613 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72538758 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.71285084 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.70949056 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68434644 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67690569 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64895879 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62816055 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61742529 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61537382 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59746193 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56711154 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.55573838 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50581231 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49826340 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.48894818 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.48879198 |
| 80 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41394365 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41233123 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40207654 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39637327 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38821623 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38412326 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.36463013 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36292840 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.33207502 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31686830 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.31092035 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30440141 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.28132429 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26906628 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.26833718 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25220751 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24952361 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24759308 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23972667 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.23753165 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.22363052 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.21859943 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.21272442 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.20869060 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20749096 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19713768 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18634835 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17522036 |
| 108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.17162287 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.16971846 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16891021 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.10230808 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09401670 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05815822 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03405949 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02217279 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1986645 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1884379 |
| 118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1862520 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1558629 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | -0.1427564 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | -0.1393845 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1194963 |
| 123 | Lysosome_Homo sapiens_hsa04142 | -0.1189264 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0989485 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0676530 |
| 126 | Proteasome_Homo sapiens_hsa03050 | -0.0388372 |
| 127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0188354 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0173378 |

